Combined Therapeutics

Combined Therapeutics, a preclinical-stage biotechnology company, is engaged in the field of immunotherapy that is transforming cancer research. The company is integrating nanomedicine and biotechnology to enhance targeting of tumor cells and the tumor microenvironment.